Precision Medicine in Cancer Supportive Care

Presented By: 
Stephen Sonis

Overview: Cancer regimen-related toxicities are often devastating consequences of current chemo- and radiotherapy regimens used for the treatment of malignancies.  But not all patients are at equal risk for developing toxicities and, for those who do, the response to specific treatment varies.  Risk and response are largely determined by genomic and epigenomic profiles.  This symposium will discuss regimen-related toxicities and present examples of how the application of genomics (and epigenomics) can be applied to effectively identify and treat patients at risk.